In lupus‐prone mice, a deficiency in NADPH oxidase has been shown to increase TLR7 and TLR9 signaling, resulting in increased autoantibody production, which exacerbates lupus risk [172]. Here, FMO5 is linked to systemic lupus erythematosus.